Fri, 01 Mar 2024 14:28:55 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://www.oncologynurseadvisor.com/wp-content/uploads/sites/13/2024/01/cropped-CTA-ONA-HEM-favicon-32x32.png 32 32 https://www.oncologynurseadvisor.com/home/cancer-types/melanoma/delayed-melanoma-care-during-pandemic-proved-costly/ Fri, 01 Mar 2024 14:00:00 +0000 https://www.oncologynurseadvisor.com/?p=116943 https://www.oncologynurseadvisor.com/home/cancer-types/melanoma/one-time-cell-therapy-amtagvi-gets-accelerated-approval-for-advanced-melanoma-2/ Mon, 26 Feb 2024 14:05:00 +0000 https://www.oncologynurseadvisor.com/?p=116801 Amtagvi is a tumor-derived autologous T cell immunotherapy designed to deploy patient-specific T cells called TIL cells to locate and attack cancer cells.]]> https://www.oncologynurseadvisor.com/home/cancer-types/melanoma/pet-ct-at-1-week-may-predict-melanoma-patients-response-to-pembrolizumab/ Tue, 13 Feb 2024 14:05:00 +0000 https://www.oncologynurseadvisor.com/?p=116558 https://www.oncologynurseadvisor.com/home/cancer-types/melanoma/early-fdg-pet-ct-can-id-metabolic-changes-in-advanced-melanoma/ Tue, 06 Feb 2024 15:00:00 +0000 https://www.oncologynurseadvisor.com/?p=116280 https://www.oncologynurseadvisor.com/home/cancer-types/skin-cancer/fda-approves-ai-device-that-helps-spot-skin-cancer/ Mon, 29 Jan 2024 15:00:00 +0000 https://www.oncologynurseadvisor.com/?p=116111 https://www.oncologynurseadvisor.com/home/cancer-types/melanoma/braf-mek-inhibitor-rechallenge-advanced-melanoma/ Wed, 24 Jan 2024 15:40:00 +0000 https://www.oncologynurseadvisor.com/?p=116108 https://www.oncologynurseadvisor.com/home/cancer-types/melanoma/starting-ist-before-ici-impact-pfs-os-advanced-melanoma/ Thu, 11 Jan 2024 15:40:00 +0000 https://www.oncologynurseadvisor.com/?p=115866 https://www.oncologynurseadvisor.com/home/cancer-types/melanoma/efficacy-shown-for-new-melanoma-therapeutic-vaccine/ Tue, 26 Dec 2023 15:00:00 +0000 https://www.oncologynurseadvisor.com/?p=114995 https://www.oncologynurseadvisor.com/home/cancer-types/skin-cancer/risk-for-skin-cancer-increased-for-patients-with-lower-extremity-lymphedema/ Thu, 21 Dec 2023 15:00:00 +0000 https://www.oncologynurseadvisor.com/?p=115010 Lymphedematous extremity 2.65 times as likely as the nonlymphedematous extremity to have skin cancer.]]> https://www.oncologynurseadvisor.com/home/cancer-types/skin-cancer/when-can-patients-with-merkel-cell-carcinoma-safely-stop-avelumab-2/ Tue, 17 Oct 2023 14:30:00 +0000 https://www.oncologynurseadvisor.com/?p=111350 Patients with advanced Merkel cell carcinoma who have achieved a complete response with avelumab may be able to safely discontinue treatment after 1 year.]]>